CURIGLIANO, GIUSEPPE
CURIGLIANO, GIUSEPPE
Dipartimento di Oncologia ed Emato-Oncologia
"Burned out" phenomenon of the testis in retroperitoneal seminoma
2006 G. Curigliano , E. Magni , G. Renne , O. De Cobelli , M. Rescigno , R. Torrisi , G. Spitaleri , E. Pietri , F. De Braud , A. Goldhirsch
"The only thing i know is that i know nothing": 5-fluorouracil in human milk
2012 F.A. Peccatori, E. Giovannetti, B. Pistilli, G. Bellettini, G. Codacci-pisanelli, N. Losekoot, G. Curigliano, H.A. Peccatori Jr., G.A. Azim, G.J. Peters
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 J.L. Zamorano, P. Lancellotti, D. Rodriguez Muñoz, V. Aboyans, R. Asteggiano, M. Galderisi, G. Habib, D.J. Lenihan, G.Y.H. Lip, A.R. Lyon, T. Lopez Fernandez, D. Mohty, M.F. Piepoli, J. Tamargo, A. Torbicki, T.M. Suter, S. Achenbach, S. Agewall, L. Badimon, G. Barón-Esquivias, H. Baumgartner, J.J. Bax, H. Bueno, S. Carerj, V. Dean, Ç. Erol, D. Fitzsimons, O. Gaemperli, P. Kirchhof, P. Kolh, P. Nihoyannopoulos, P. Ponikowski, M. Roffi, A. Vaz Carneiro, S. Windecker, G. Minotti, D. Cardinale, G. Curigliano, E. De Azambuja, S. Dent, C. Ero, M.S. Ewer, D. Farmakis, R. Fietkau, P. Kohl, P. Mcgale, J. Ringwald, J. Schulz-Menger, J. Stebbing, R.K. Steiner, S. Szmit
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines : the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
2017 J.L. Zamorano, P. Lancellotti, D. Rodriguez Muñoz, V. Aboyans, R. Asteggiano, M. Galderisi, G. Habib, D.J. Lenihan, G.Y.H. Lip, A.R. Lyon, T. Lopez Fernandez, D. Mohty, M.F. Piepoli, J. Tamargo, A. Torbicki, T.M. Suter, S. Achenbach, S. Agewall, L. Badimon, G. Barón-Esquivias, H. Baumgartner, J.J. Bax, H. Bueno, S. Carerj, V. Dean, C. Erol, D. Fitzsimons, O. Gaemperli, P. Kirchhof, P. Kolh, P. Lancellotti, P. Nihoyannopoulos, P. Ponikowski, M. Roffi, A. Torbicki, A. Vaz Carneiro, S. Windecker, G. Minotti, D. Cardinale, S. Carerj, G. Curigliano, E. de Azambuja, S. Dent, M.S. Ewer, D. Farmakis, R. Fietkau, P. Mcgale, J. Ringwald, J. Schulz-Menger, J. Stebbing, R. Steiner, S. Szmit
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)
2017 F. Cardoso, A. Costa, E. Senkus, M. Aapro, F. Andre, C.H. Barrios, J. Bergh, G. Bhattacharyya, L. Biganzoli, M.J. Cardoso, L. Carey, D. Corneliussen-James, G. Curigliano, V. Dieras, N. El Saghir, A. Eniu, L. Fallowfield, D. Fenech, P. Francis, K. Gelmon, A. Gennari, N. Harbeck, C. Hudis, B. Kaufman, I. Krop, M. Mayer, H. Meijer, S. Mertz, S. Ohno, O. Pagani, E. Papadopoulos, F. Peccatori, F. Penault-Llorca, M.J. Piccart, J.Y. Pierga, H. Rugo, L. Shockney, G. Sledge, S. Swain, C. Thomssen, A. Tutt, D. Vorobiof, B. Xu, L. Norton, E. Winer
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
2017 F. Cardoso, A. Costa, E. Senkus, M. Aapro, F. André, C.H. Barrios, J. Bergh, G. Bhattacharyya, L. Biganzoli, M.J. Cardoso, L. Carey, D. Corneliussen-James, G. Curigliano, V. Dieras, N. El Saghir, A. Eniu, L. Fallowfield, D. Fenech, P. Francis, K. Gelmon, A. Gennari, N. Harbeck, C. Hudis, B. Kaufman, I. Krop, M. Mayer, H. Meijer, S. Mertz, S. Ohno, O. Pagani, E. Papadopoulos, F. Peccatori, F. Penault-Llorca, M.J. Piccart, J.Y. Pierga, H. Rugo, L. Shockney, G. Sledge, S. Swain, C. Thomssen, A. Tutt, D. Vorobiof, B. Xu, L. Norton, E. Winer
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
2017 F. Cardoso, A. Costa, E. Senkus, M. Aapro, F. André, C.H. Barrios, J. Bergh, G. Bhattacharyya, L. Biganzoli, M.J. Cardoso, L. Carey, D. Corneliussen-James, G. Curigliano, V. Dieras, N. El Saghir, A. Eniu, L. Fallowfield, D. Fenech, P. Francis, K. Gelmon, A. Gennari, N. Harbeck, C. Hudis, B. Kaufman, I. Krop, M. Mayer, H. Meijer, S. Mertz, S. Ohno, O. Pagani, E. Papadopoulos, F. Peccatori, F. Penault-Llorca, M.J. Piccart, J.Y. Pierga, H. Rugo, L. Shockney, G. Sledge, S. Swain, C. Thomssen, A. Tutt, D. Vorobiof, B. Xu, L. Norton, E. Winer
4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study
1998 G. Flamini, G. Romano, G. Curigliano, A. Chiominto, G. Capelli, A. Boninsegna, C. Signorelli, L. Ventura, R.M. Santella, A. Sgambato, A. Cittadini
4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)
2018 F. Cardoso, E. Senkus, A. Costa, E. Papadopoulos, M. Aapro, F. André, N. Harbeck, B. Aguilar Lopez, C.H. Barrios, J. Bergh, L. Biganzoli, C.B. Boers-Doets, M.J. Cardoso, L.A. Carey, J. Cortés, G. Curigliano, V. Dié Ras, N.S. El Saghir, A. Eniu, L. Fallowfield, P.A. Francis, K. Gelmon, S.R.D. Johnston, B. Kaufman, S. Koppikar, I.E. Krop, M. Mayer, G. Nakigudde, B.V. Offersen, S. Ohno, O. Pagani, S. Paluch-Shimon, F. Penault-Llorca, A. Prat, H.S. Rugo, G.W. Sledge, D. Spence, C. Thomssen, D.A. Vorobiof, B. Xu, L. Norton, E.P. Winer
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
2020 F. Cardoso, S. Paluch-Shimon, E. Senkus, G. Curigliano, M.S. Aapro, F. Andre, C.H. Barrios, J. Bergh, G.S. Bhattacharyya, L. Biganzoli, F. Boyle, M.-. Cardoso, L.A. Carey, J. Cortes, N.S. El Saghir, M. Elzayat, A. Eniu, L. Fallowfield, P.A. Francis, K. Gelmon, J. Gligorov, R. Haidinger, N. Harbeck, X. Hu, B. Kaufman, R. Kaur, B.E. Kiely, S.-. Kim, N.U. Lin, S.A. Mertz, S. Neciosup, B.V. Offersen, S. Ohno, O. Pagani, A. Prat, F. Penault-Llorca, H.S. Rugo, G.W. Sledge, C. Thomssen, D.A. Vorobiof, T. Wiseman, B. Xu, L. Norton, A. Costa, E.P. Winer
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer
2019 A. Esposito, G. Viale, C. Criscitiello, G. Curigliano
A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer
2018 C. Criscitiello, M.A. Bayar, G. Curigliano, F.W. Symmans, C. Desmedt, H. Bonnefoi, B. Sinn, G. Pruneri, C. Vicier, J.Y. Pierga, C. Denkert, S. Loibl, C. Sotiriou, S. Michiels, F. André
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
2014 G. Aurilio, D. Disalvatore, G. Pruneri, V. Bagnardi, G. Viale, G. Curigliano, L. Adamoli, E. Munzone, A. Sciandivasci, F. De Vita, A. Goldhirsch, F. Nolè
A new approach to assess drug sensitivity in cells for novel drug discovery
2018 L. Mazzarella, G. Curigliano
A non-randomized dose-escalation phase i trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
2016 S.A. Limentani, M. Csampone, T. Dorval, G. Curigliano, R. de Boer, C. Vogel, S. White, T. Bachelot, J. Canon, M. Disis, A. Awada, M. Berlière, F. Amant, E. Levine, W. Burny, A. Callegaro, P.M. de Sousa Alves, J. Louahed, V. Brichard, F.F. Lehmann
A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC)
2016 G. Curigliano, S. Loibl, V. Müller, X. Pivot, A. Wardley, D. Cameron
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, With or Without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer
2021 K. Jhaveri, D. Juric, Y. Yap, S. Cresta, R.M. Layman, F.P. Duhoux, C. Terret, S. Takahashi, J. Huober, N. Kundamal, Q. Sheng, A. Balbin, Y. Ji, W. He, A. Crystal, S. De Vita, G. Curigliano
A Phase I/II Study of Rovalpituzumab Tesirine in Combination With Nivolumab ± Ipilimumab in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer
2021 J. Malhotra, P. Nikolinakos, T. Leal, J. Lehman, D. Morgensztern, J.D. Patel, J.M. Wrangle, G. Curigliano, L. Greillier, M.L. Johnson, N. Ready, G. Robinet, S. Lally, D. Maag, R. Valenzuela, V. Blot, B. Besse
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer
2016 G. Curigliano, G. Romieu, M. Campone, T. Dorval, L. Duck, J. Canon, C. Roemer-Becuwe, M. Roselli, S. Neciosup, W. Burny, A. Callegaro, P.M. de Sousa Alves, J. Louahed, V. Brichard, F.F. Lehmann
A phase Ib dose-finding study of alpelisib (ALP; BYL719) and paclitaxel (PTX) in advanced solid tumors (aST)
2016 J. Rodón, G. Curigliano, J. Delord, W. Harb, A. Azaro, V. Donnet, Y. Han, L. Blumenstein, C. Wilke, J.T. Beck